Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-04.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 82

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 83
A case of the lupus syndrome induced by hydralazine.

Journal of the Korean Pediatric Society 1991;34(5):736-739.
Published online May 31, 1991.
A case of the lupus syndrome induced by hydralazine.
Beom Soo Park, Joong Gon Kim, Yong Soo Yun
Department of Pediatrics, Seoul National University Collage of Medicine, Seoul, Korea
Hydralazine에 의하여 유발된 Lupus Syndrome 1례
박범수, 김중곤, 윤용수
서울대학교 의과대학 소아과학교실
Received: 28 September 1990   • Accepted: 29 November 1990
Abstract
A reversible syndrome resembling systemic lupus erythematosus is induced by hydralazine which has been used in treatment of hypertension or congestive heart failure. The incidence of the lupus syndrome induced by hydralazine was estimated at 6.8% in adults (Cameron, 1984) but there was few reports in children. A 9 year old girl had arthralgia, fever, splenomegaly, pleurisy and oral ulcer after 62 months of hydralazine therapy《3〜4 mg/kg/day) for congestive heart failure due to dilated cardiomyopathy. Laboratory work ups showed positive fluorescent antinuclear antibody (FANA), positive LE cell, pancytopenia, decreased level of C4 and CH50, positive anti-ds DNA antibody, proteinuria and hematuria. Clinical symptoms and laboratory abnormalities returned to normal after steroid therapy with discontinuing the hydralazine therapy. We report a case of the lupus syndrome induced by hydralazine in a child who had suffered form congestive heart failure due to dilaged cardiomyopathy with a brief review of literatures.
Key Words: Hydralazine, Lupus syndrome


METRICS Graph View
  • 896 View
  • 3 Download